Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
RVMD
#442
Revolution Medicines, Inc. Common Stock
152.540
0
USD
+3.76%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+3.76%
Changement Mensuel
+55.37%
Evolution sur 6 mois
+175.34%
Changement Annuel
+175.34%
Clôture Précédente
147.010
0
Open
152.540
0
Bid
Ask
Low
152.540
0
High
152.540
0
Volume
160
Marchés
Actions des Marchés US
Soins de Santé
RVMD
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
185.91 M
186.27 M
186.93 M
193.32 M
198.17 M
—
Valuation ratios
Enterprise value
7.59 B
6.25 B
6.47 B
8.81 B
15.4 B
36.94 B
Price to earnings ratio
-12.22
-8.82
-8.16
-9.02
-13.39
-39.38
Price to sales ratio
—
5 246.72
3 688.56
3 511.79
—
—
Price to cash flow ratio
-13.16
-10.35
-9.64
-11.31
-16.87
-48.17
Price to book ratio
3.24
0.81
0.84
1.09
9.28
12.02
Enterprise value to EBITDA ratio
-10.44
-7.63
-7.01
-8.33
-12.82
-35.79
Profitability ratios
Return on assets %
-0.08
-0.09
-0.1
-0.14
-0.15
-0.48
Return on equity %
-0.09
-0.1
-0.13
-0.19
-0.22
-0.65
Return on invested capital %
-309.76
—
—
—
-310.11
—
Gross margin %
—
100
100
100
100
400
Operating margin %
—
-18.99 K
-43.4 K
-50.12 K
-43.31 K
-155.81 K
EBITDA margin %
—
-19.51 K
-44.24 K
-50.57 K
-43.4 K
-157.72 K
Net margin %
—
-16.83 K
-40.62 K
-48.52 K
-43.7 K
-149.67 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
14.2
13.46
11.79
8.05
7.14
40.45
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.82
-1.03
-1.18
-1.1
-1.44
-4.75
EBIT per share
-1.29
-1.27
-1.4
-1.66
-1.9
-6.23
EBITDA per share
-1.33
-1.32
-1.43
-1.68
-1.91
-6.33
Total debt per share
—
—
—
—
—
—
Cash per share
13.65
11.18
11.33
10.21
10.65
43.37
Net current asset value per share
13.88
11.35
11.54
10.45
10.91
44.25
Tangible book value per share
13.5
11.05
9.89
8.44
8.58
37.96
Working capital per share
12.9
10.5
10.56
9.15
9.39
39.6
Book value per share
13.5
11.05
9.89
8.44
8.58
37.96
Nouvelles
Revolution Medicines lève 2 milliards de dollars via des offres d’actions et d’obligations
Revolution Medicines: "Strong Buy" On Daraxonrasib Win And Expansions Underway (RVMD)
Johnson & Johnson Q2 Earnings Review: Why You Should Be Buying The Stock Today (NYSE:JNJ)
RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data
Mizuho réitère sa recommandation sur Revolution après un essai positif
H.C. Wainwright relève l’objectif de cours de Revolution Medicines à 169$
RBC Capital relève l’objectif de cours de Revolution après l’étude RASolute
Evercore ISI relève l’objectif de cours de Revolution sur fond de résultats d’essai
Stocks Settle Higher in Hopes for an Agreement to End the Iran War
Revolution Medicines prévoit une double émission de 1 milliard de dollars
Revolution Medicines Soars on Phase 3 Trial Results. Is It Too Late to Buy?
Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside (RVMD)